Specific bacterial genotypes of Mycobacterium tuberculosis cause extensive dissemination and brain infection in an experimental model
Received 15 December 2009; received in revised form 7 May 2010; accepted 10 May 2010. published online 28 June 2010.
Summary
Meningeal tuberculosis is a severe type of extrapulmonary disease, which is thought to begin with respiratory infection, followed by hematogenous dissemination and brain infection. Host genetic susceptibility factors and specific mycobacterial substrains could be involved in its development. From an epidemiological study in Colombia, we selected three Mycobacterium tuberculosis clinical strains isolated from the cerebrospinal fluid (CSF) of patients with meningeal tuberculosis, and used them to infect BALB/c mice through the intratracheal route. These strains showed a distinctive spoligotype pattern. The course of infection in terms of strain virulence (mice survival, bacillary loads in lungs), bacilli dissemination and extrapulmonary infection (bacilli loads in blood, brain, liver, kidney and spleen), and immune responses (cytokine expression determined by real time PCR in brain and lung) was studied and compared with that induced by the laboratory strain H37Rv and other five clinical strains isolated from patients with pulmonary TB. All the clinical isolates from meningeal TB patients disseminated extensively through the hematogenous route infecting the brain, producing inflammation in the cerebral parenchyma and meninges, whereas H37Rv and clinical isolates from pulmonary TB patients showed very limited efficiency to infect the brain. Thus, it seems that mycobacterial strains with a distinctive genotype are able to disseminate extensively after the respiratory infection and infect the brain.
aExperimental Pathology Section, Department of Pathology, National Institute of Medical Sciences, Mexico City, Mexico
bDepartment of Immunology, Biomedical Research Institute, National Autonomous University of Mexico, Mexico City, Mexico
cMycobacteria Group, Research Division, National Institute of Health, Bogotá, Colombia
dDepartment of Pathology, National Institute of Neurology and Neurosurgery, Mexico City, Mexico
Corresponding author. Experimental Pathology Section, Department of Pathology, National Institute of Medical Sciences and Nutrition “Salvador Zubirán”, Calle Vasco de Quiroga 15, Tlalpan, CP 14000, Mexico City, Mexico. Tel./fax: +52 55 54 85 34 91.